Home › Biliary Tract Cancer › Pennsylvania › Philadelphia
Biliary Tract Cancer clinical trials in Philadelphia, PA
6 studies for Biliary Tract Cancer are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
RecruitingPhase 3
- Research Site, Philadelphia
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
RecruitingPhase 1/2
- Avenzo Therapeutics Recruiting Site, Philadelphia
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
RecruitingPhase 1
- Sidney Kimmel Comprehensive Center at Jefferson, Philadelphia
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
RecruitingPhase 2
- Thomas Jefferson University, Philadelphia
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
RecruitingPhase 1
- Sidney Kimmel Cancer Center, Philadelphia
Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC
RecruitingPhase 2
- University of Pennsylvania, Abramson Cancer Center, Philadelphia
Biliary Tract Cancer trials in other cities
- Houston, TX18 studies
- Los Angeles, CA11 studies
- Boston, MA11 studies
- New York City, NY10 studies
- Nashville, TN9 studies
- Baltimore, MD8 studies
- San Antonio, TX8 studies
- Washington, DC7 studies
- Pittsburgh, PA7 studies
- Arlington, VA7 studies
- Madison, WI6 studies
- Columbus, OH6 studies
Other studies in Philadelphia
- Cancer (all types)59 studies
- Breast Cancer56 studies
- Non-Small Cell Lung Cancer51 studies
- Metastatic Cancer46 studies
- Prostate Cancer44 studies
- Colorectal Cancer44 studies
- Ovarian Cancer44 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Heart Failure31 studies
- Endometrial Cancer28 studies
- Depression26 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.